I blurted out. My voice mirrored my grandmother’s. I don’t remember if the child was experiencing a specific ailment commonly coupled with his Down syndrome, such as leukemia or a structural heart or ...

"The acceptance of our Fragile X syndrome OLE data as a podium presentation at AAN underlines the significant unmet need in FXS, and the potential for ZYN002 to become the first-and-only approved ...

I made notes in his medical records, which I revisited a few years later when it was confirmed that DiGeorge syndrome was "located" on the 22nd chromosome (22q11). This discovery led to it being ...

Background The recurrent ∼600 kb 16p11.2 BP4-BP5 deletion is among the most frequent known genetic ... birth asphyxia, fetal alcohol syndrome, and/or prematurity <30 weeks. In the European series, ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Celine Dion is "getting back into the swing of things" after being diagnosed with stiff person syndrome in 2022. However, the singer – who turns 57 on March 30 – first noticed symptoms in 2008 ...

The Food and Drug Administration approved a medication this week known as VYKAT XR to treat hyperphagia — or an incessant feeling of hunger — in kids and adults with Prader-Willi syndrome. The ...

But Walz absolutely has caught a case of “main character” syndrome. He seems to have convinced himself that he is a major player. That the Democratic party is clamoring for what he is selling.

Every month she gets money from the Division of Developmental Disabilities for Aries who has a rare genetic condition called 5Q31.3 Full Deletion Syndrome. However, funding could run out for the ...

Disease name: Trimethylaminuria (TMAU), also known as "fish odor syndrome" Affected populations: TMAU is a rare metabolic condition that causes a person to smell like rotten fish. The condition is ...

Diazoxide choline extended-release is the first FDA-approved therapy to address hyperphagia in Prader-Willi syndrome. Soleno Therapeutics announced the medication will be available beginning in April.

March 27, 2025 – The FDA has approved a drug to treat a key symptom of a rare life-threatening genetic disorder known as Prader-Willi syndrome (PWS) in adults and children ages 4 or older.